GlassScriptPhysician profile
Veena Prabhu
NPI 1053421271
$15,040.91
in general payments reported to CMS, 2019-2025
57 companies · $2,786 in 2025
The $2,786 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,457 · 2020: $1,235 · 2021: $2,625 · 2022: $1,859 · 2023: $2,384 · 2024: $2,695 · 2025: $2,786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,784 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,784.14 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,920.11 | 2020-2025 | |
| Novo Nordisk INC | $1,459.47 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Biohaven Pharmaceuticals, INC. | $1,281.13 | 2021 | |
| Amgen INC. | $941.45 | 2019-2025 | Prolia, Evenity, Krystexxa |
| Astrazeneca Pharmaceuticals LP | $902.35 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $900.11 | 2019-2025 | |
| Lilly USA, LLC | $860.60 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Phathom Pharmaceuticals, INC. | $757.83 | 2024-2025 | Voquezna |
| Astellas Pharma US INC | $469.26 | 2019-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $460.65 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Glaxosmithkline, LLC. | $446.43 | 2019-2025 | Benlysta, Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $430.06 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $379.15 | 2019-2025 | Xifaxan |
| Edwards Lifesciences Corporation | $268.01 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| E.R. Squibb & Sons, L.L.C. | $258.28 | 2019-2025 | Eliquis |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veena Prabhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.